GO
Loading...

Market Outlook

More

  • Amazon Bounce 'A Knee-Jerk Reaction': Kessler     Thursday, 25 Oct 2012 | 5:17 PM ET

    Swings in the price of Amazon stock after it reported quarterly earnings may have been unwarranted, Aaron Kessler of Raymond James says.

  • Amazon Falling After Hours     Thursday, 25 Oct 2012 | 5:15 PM ET

    Amazon.com missed on its EPS and revenues for Q3, and the stock is well off session lows. Aaron Kessler, Raymond James technology analyst, takes a closer look; and Larry Haverty, Gabelli Multimedia Trust, weighs in on Apple's earnings.

  • CNBC's Maria Bartiromo reports Amazon's quarterly earnings, with Dan Morgan, Synovus Trust; Gary Shilling, A. Gary Shilling; Ben Pace, Deutsche Bank Private Wealth Management; and CNBC's Jeff Cox.

  • CNBC's Bertha Coombs discusses the day's activity in the commodities markets and looks at where oil and precious metals are likely headed tomorrow.

  • Where Will Markets Close?     Thursday, 25 Oct 2012 | 3:40 PM ET

    Where to invest ahead of the close, with David Steinberg, DLS Capital Management; Dave MacEwen, American Century Investments; and CNBC's Bob Pisani.

  • What Does the Market Need?     Thursday, 25 Oct 2012 | 3:00 PM ET

    Discussing how earnings fit into the valuation of the market now, with Jim Moffett, Scout Investments; Brian Rehling, Wells Fargo Advisors; James Bianco, Bianco Research; and CNBC's Rick Santelli.

  • Einhorn to Quantitative Easing: Drop Dead Thursday, 25 Oct 2012 | 1:26 PM ET

    Hedge-fund manager David Einhorn is a big critic of quantitative easing — and he thinks the U.S.’s current monetary policy should essentially be reversed.

  • 3 Factors to Get Bearish: Strategist     Thursday, 25 Oct 2012 | 12:18 PM ET

    Three hurdles are exerting pressure on stocks, Wells Fargo Securities Institutional Equity Strategist Gina Martin Adams says.

  • Spain Must Request Euro Rescue Funds: ECB Pro     Thursday, 25 Oct 2012 | 12:08 PM ET

    Lorenzo Bini Smaghi, former ECB governor and visiting scholar at Weatherhead Center for International Affairs, Harvard University, adds that the current economic situation in Europe justifies a weaker euro.

  • Fourth and Goal with Moglia     Thursday, 25 Oct 2012 | 8:48 AM ET

    "You have to understand your skill sets," said Joe Moglia, Coastal Carolina head football coach (2012), and TD Ameritrade chairman, discussing how people can overcome challenges and find jobs in a tough economy.

  • Trader Buzz Before the Bell     Thursday, 25 Oct 2012 | 7:32 AM ET

    A look at what traders are watching before the opening bell, with John Netto, M3 Capital, and Scott Nations, NationsShares.

  • Asian Shares Rise, Earnings Worries Remain Thursday, 25 Oct 2012 | 6:08 AM ET

    Asian shares rose on Thursday as signs of recovery in China and the United States eased fears of deteriorating global growth, though generally weak corporate earnings continued to make investors wary.

  • Pre-Market Report: What You Need to Know     Thursday, 25 Oct 2012 | 6:00 AM ET

    A look at the U.S. markets ahead of the open, with CNBC's Ross Westgate, as corporate leaders urge Congress to use spending cuts and tax increases to reduce the nation's deficits.

  • Walker Plans Barclays Board Clear-Out Thursday, 25 Oct 2012 | 2:08 AM ET

    Sir David Walker is planning a clean sweep of Barclays’ board after he formally becomes chairman of the scandal-tainted bank next week and will also oversee the replacement of some key executive positions. The FT reports.

  • Cameron Seizes on GDP ‘Good News’ Thursday, 25 Oct 2012 | 1:45 AM ET

    David Cameron on Wednesday promised “the good news will keep coming” as his error-prone government prepared to seize on new data that is expected to show Britain’s double-dip recession is over, the Financial Times reports.

  • Am I Diversified? Cramer's Call!     Wednesday, 24 Oct 2012 | 6:58 PM ET

    Viewers tweet or call Mad Money host Jim Cramer and share with him their top five holdings to see if their portfolio is diversified enough.

  • NPS Pharmaceuticals CEO on Orphan Drugs     Wednesday, 24 Oct 2012 | 6:45 PM ET

    NPS Pharmaceuticals president & CEO Dr. Francois Nader, discusses strategies his company uses to finding value for shareholders, and appealing to the FDA.

  • Cramer: Facebook's Move Up 19% Is Justified     Wednesday, 24 Oct 2012 | 6:25 PM ET

    Mad Money host Jim Cramer takes a close look at Facebook's Q3 earnings.

  • Getting a read on the state of the consumer, with Jarden Corporation Executive Chairman Martin Franklin. Franklin says his company spends "1 million per day on brand investment" which relates to investments on new products and promoting those products.

  • Earnings Driving the Markets?     Wednesday, 24 Oct 2012 | 6:00 PM ET

    Mad Money host Jim Cramer discusses the market action driven by companies' quarterly earnings.